USD 24.5
(-6.45%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 141.94 Million | 147.04 Million | 86.97 Million | 76.3 Million | 101.19 Million |
Net Income | -19.74 Million | 115.89 Million | 18.11 Million | -8.85 Million | 35.88 Million |
Depreciation & Amortization | 81.74 Million | 63.73 Million | 60.84 Million | 58.3 Million | 64.72 Million |
Deferred income taxes | 61.94 Million | -127.6 Million | -60.84 Million | -58.3 Million | -64.72 Million |
Stock-based compensation | 32.23 Million | -10.76 Million | 1.4 Million | -544 Thousand | 3.29 Million |
Change in working capital | -3.57 Million | -9 Million | -12.36 Million | 16.31 Million | -2.68 Million |
Other non-cash items | -10.66 Million | 114.79 Million | 79.8 Million | 69.39 Million | 64.69 Million |
Investing Cash Flow | -120.66 Million | -84.58 Million | -43.31 Million | -70.8 Million | -104.36 Million |
Investments in PPE | -120.66 Million | -84.58 Million | -43.31 Million | -70.83 Million | -104.42 Million |
Acquisitions | - | - | - | - | - |
Investment purchases | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - |
Other Investing Activities | -120.48 Million | -84.57 Million | -43.19 Million | 25 Thousand | 53 Thousand |
Financing Cash Flow | -30.73 Million | -57.8 Million | -42.58 Million | -5.52 Million | -41 Thousand |
Debt repayment | -31 Million | -21.8 Million | -31.5 Million | -15.5 Million | -8 Million |
Dividends payments | -57.99 Million | -36 Million | -12 Million | - | -25 Million |
Common Stock Repurchased | -248 Thousand | - | - | - | - |
Common Stock Issuance | 30.62 Million | - | - | - | - |
Other Financing Activities | 27.88 Million | -1.8 Million | 913 Thousand | 9.97 Million | 32.95 Million |
Accounts receivables | -810 Thousand | -10.76 Million | -15.95 Million | 18.66 Million | -4.11 Million |
Accounts payables | 2.4 Million | -147 Thousand | -997 Thousand | -524 Thousand | 2.4 Million |
Inventory | -5.16 Million | - | 4.62 Million | -1.85 Million | -978 Thousand |
Other working capital | -4000.00 | 1.9 Million | -26 Thousand | 25 Thousand | 9000.00 |
Cash at beginning of period | 10 Million | 2.8 Million | 1.73 Million | 1.76 Million | 4.97 Million |
Cash at end of period | 552 Thousand | 10 Million | 2.8 Million | 1.73 Million | 1.76 Million |
Capital Expenditure | -120.66 Million | -84.58 Million | -43.31 Million | -70.83 Million | -104.42 Million |
Effect of forex changes on cash | - | -3.62 Million | - | - | - |
Net cash flow / Change in cash | -9.45 Million | 7.2 Million | 1.06 Million | -27 Thousand | -3.21 Million |
Free Cash Flow | 21.27 Million | 62.45 Million | 43.65 Million | 5.47 Million | -3.22 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 17.44 Million | 10.92 Million | -2.18 Million | 19.91 Million | -19.74 Million | -1.46 Million |
Depreciation & Amortization | 24.91 Million | 25.31 Million | 23.54 Million | 13.03 Million | 81.74 Million | 34.67 Million |
Deferred income taxes | 6.24 Million | 3.28 Million | -475 Thousand | 15.56 Million | 61.94 Million | -797 Thousand |
Stock-based compensation | 2.2 Million | 2.04 Million | 1.6 Million | 1.68 Million | 32.23 Million | 1.14 Million |
Change in working capital | 3.11 Million | -5.19 Million | 2.08 Million | -14.09 Million | -3.57 Million | -1.65 Million |
Other non-cash items | -8.18 Million | 59.32 Million | 58.51 Million | -4.47 Million | -10.66 Million | 164 Thousand |
Investing Cash Flow | -17.22 Million | -37.66 Million | -32.21 Million | -43.2 Million | -120.66 Million | -34.17 Million |
Investments in PPE | 69.81 Million | -37.66 Million | -32.21 Million | -43.2 Million | -120.66 Million | -34.17 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -87.03 Million | - | -32.18 Million | -120.48 Million | -120.48 Million | - |
Financing Cash Flow | -26.2 Million | 1.24 Million | -6.38 Million | 10.37 Million | -30.73 Million | 500 Thousand |
Debt repayment | -12.22 Million | -16.85 Million | -16.87 Million | -2 Million | -31 Million | -5 Million |
Dividends payments | -15.63 Million | -15.6 Million | -16.31 Million | -14.52 Million | -57.99 Million | -14.49 Million |
Common Stock Repurchased | 6.94 Million | - | -6.94 Million | - | -248 Thousand | - |
Common Stock Issuance | - | - | - | - | 30.62 Million | - |
Other Financing Activities | -5.28 Million | -145 Thousand | -6.94 Million | 26.89 Million | 27.88 Million | 19.99 Million |
Accounts receivables | 1.4 Million | -5.03 Million | 3.63 Million | -6.71 Million | -810 Thousand | -11.79 Million |
Accounts payables | 486 Thousand | -2.82 Million | 1.39 Million | -3.18 Million | 2.4 Million | 3.38 Million |
Inventory | - | - | - | -6.17 Million | -5.16 Million | 6.77 Million |
Other working capital | 277 Thousand | 2.66 Million | -2.93 Million | 1.98 Million | -4000.00 | -27 Thousand |
Cash at beginning of period | 121 Thousand | 1.37 Million | 552 Thousand | 1.74 Million | 10 Million | 3.36 Million |
Cash at end of period | 2.42 Million | 121 Thousand | 1.37 Million | 552 Thousand | 552 Thousand | 1.74 Million |
Capital Expenditure | 69.81 Million | -37.66 Million | -32.21 Million | -43.2 Million | -120.66 Million | -34.17 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 2.3 Million | -1.25 Million | 825 Thousand | -1.19 Million | -9.45 Million | -1.61 Million |
Free Cash Flow | 115.54 Million | -2.5 Million | 7.2 Million | -11.57 Million | 21.27 Million | -2.11 Million |
1082
STARHEALTH
VRNS
AMAG
CSED3
BIOSK